Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Which Blue Chip Coin To Invest In First helps newcomers pinpoint initial investments. This guide outlines criteria for selection and how to diversify responsibly.
24,229 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...
A growing number of retirees moved cash into Treasury bills to lock in near-4% yields. But the tax system on Social S...
Gold and mining stocks have faced heightened volatility. This week, eldorado gold stock diving has sparked questions ...
London moves away from wallet limits toward a single market cap on sterling stablecoins, signaling a friendlier frame...
A leading market strategist says fears about AI are overblown as investors rotate into buy opportunities beyond megac...
Tech ETFs can power long-term gains, especially with AI-driven growth. If you invested $1,000 years ago in VGT, you’d...
May 2026 hands investors a surprise: a big jump in M2 money supply could rekindle inflation pressures. Markets weigh ...
SPYI has surpassed $10 billion in assets, offering a near-12% annualized yield through a credit-spread options overla...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
A rare down year for Visa invites a closer look. This article breaks down why Visa is a cash-flow machine, what’s dri...
A Michigan retiree moving to Sarasota learns the hard truth: Medicare Advantage plans are local. The move triggers en...